• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Personalizing beta-blockade in septic shock: finding the right rhythm and rate for the right patient.

作者信息

Duška František, Rehberg Sebastian

机构信息

Department of Anaesthesia and Intensive Care of The Third Faculty of Medicine and Královské Vinohrady University Hospital, Charles University, Prague, Czech Republic.

Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Bielefeld, Germany.

出版信息

Intensive Care Med. 2025 Jan;51(1):235-236. doi: 10.1007/s00134-024-07731-x. Epub 2024 Nov 26.

DOI:10.1007/s00134-024-07731-x
PMID:39589504
Abstract
摘要

相似文献

1
Personalizing beta-blockade in septic shock: finding the right rhythm and rate for the right patient.脓毒性休克中β受体阻滞剂的个体化应用：为合适的患者找到合适的节律和心率。
Intensive Care Med. 2025 Jan;51(1):235-236. doi: 10.1007/s00134-024-07731-x. Epub 2024 Nov 26.
2
Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days.在严重脓毒症和脓毒性休克的急性期持续使用慢性β受体阻滞剂与 90 天内死亡率降低相关。
Br J Anaesth. 2017 Oct 1;119(4):616-625. doi: 10.1093/bja/aex231.
3
Prognosis of β-adrenergic blockade therapy on septic shock and sepsis: A systematic review and meta-analysis of randomized controlled studies.β-肾上腺素能阻滞剂治疗感染性休克和败血症的预后：系统评价和随机对照研究的荟萃分析。
Cytokine. 2020 Feb;126:154916. doi: 10.1016/j.cyto.2019.154916. Epub 2019 Nov 19.
4
Risk, rate or rhythm control for new onset supraventricular arrhythmia during septic shock: protocol for the CAFS multicentre, parallel-group, open-label trial.感染性休克期间新发室上性心律失常的风险、心率或节律控制：CAFS多中心、平行组、开放标签试验方案
BMJ Open. 2025 Apr 1;15(4):e090404. doi: 10.1136/bmjopen-2024-090404.
5
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*.严重脓毒症和感染性休克中的肌钙蛋白升高：左心室舒张功能障碍和右心室扩张的作用*。
Crit Care Med. 2014 Apr;42(4):790-800. doi: 10.1097/CCM.0000000000000107.
6
Right ventricular function of patients with septic shock: clinical significance.感染性休克患者的右心室功能：临床意义
Zhonghua Wai Ke Za Zhi. 2000 Jul;38(7):488-92.
7
Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study.脓毒症和脓毒性休克中孤立性右心室功能障碍的预后影响：一项为期8年的历史性队列研究。
Ann Intensive Care. 2017 Sep 7;7(1):94. doi: 10.1186/s13613-017-0319-9.
8
Right ventricular dysfunction in patients with septic shock.感染性休克患者的右心室功能障碍
Intensive Care Med. 1988;14 Suppl 2:488-91. doi: 10.1007/BF00256967.
9
Right heart in septic shock: prospective observational study.右心在感染性休克中的作用：前瞻性观察研究。
J Intensive Care. 2016 Jun 7;4:38. doi: 10.1186/s40560-016-0159-y. eCollection 2016.
10
Sepsis and beta-blockade: a look into diastolic function.脓毒症与β受体阻滞剂：对舒张功能的探讨
Curr Med Res Opin. 2015;31(10):1827-8. doi: 10.1185/03007995.2015.1073147. Epub 2015 Aug 20.

引用本文的文献

1
[Vasoactive agents in septic shock-individualized strategies].[脓毒性休克中的血管活性药物——个体化策略]
Med Klin Intensivmed Notfmed. 2025 Apr 24. doi: 10.1007/s00063-025-01272-x.
2
Landiolol in patients with septic shock.脓毒性休克患者使用兰地洛尔的情况。
Intensive Care Med. 2025 Jan;51(1):221. doi: 10.1007/s00134-024-07706-y. Epub 2024 Nov 11.

本文引用的文献

1
Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).兰地洛尔用于感染性休克和持续性心动过速患者的心率控制。一项多中心随机临床试验（Landi-SEP）。
Intensive Care Med. 2024 Oct;50(10):1622-1634. doi: 10.1007/s00134-024-07587-1. Epub 2024 Sep 19.
2
Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review.在重症监护中使用兰地洛尔治疗新发房颤：一项系统评价
J Clin Med. 2024 May 17;13(10):2951. doi: 10.3390/jcm13102951.
3
The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume.
比较普罗帕酮与胺碘酮治疗脓毒性休克伴发的上性心律失常患者的结局与收缩末期左房容积相关。
Eur Heart J Acute Cardiovasc Care. 2024 May 28;13(5):414-422. doi: 10.1093/ehjacc/zuae023.
4
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.地佐辛和脓毒性休克患者的器官衰竭：STRESS-L 随机临床试验。
JAMA. 2023 Nov 7;330(17):1641-1652. doi: 10.1001/jama.2023.20134.
5
Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.普罗帕酮与胺碘酮治疗感染性休克时的室上性心律失常：一项随机对照试验。
Intensive Care Med. 2023 Nov;49(11):1283-1292. doi: 10.1007/s00134-023-07208-3. Epub 2023 Sep 12.
6
Amiodarone but not propafenone impairs bioenergetics and autophagy of human myocardial cells.胺碘酮而非普罗帕酮会损害人心肌细胞的生物能量学和自噬。
Toxicol Appl Pharmacol. 2023 Oct 15;477:116676. doi: 10.1016/j.taap.2023.116676. Epub 2023 Sep 3.
7
Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.心率控制药物治疗脓毒症相关性心房颤动的疗效比较。
Chest. 2021 Apr;159(4):1452-1459. doi: 10.1016/j.chest.2020.10.049. Epub 2020 Oct 24.
8
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.兰地洛尔治疗脓毒症相关快速性心律失常的疗效和安全性（J-Land 3S）：一项多中心、开放标签、随机对照试验。
Lancet Respir Med. 2020 Sep;8(9):863-872. doi: 10.1016/S2213-2600(20)30037-0. Epub 2020 Mar 31.
9
Hemodynamic response of restoring sinus rhythm in critically ill patients with atrial fibrillation.严重房颤患者恢复窦性心律的血液动力学反应。
Am J Emerg Med. 2020 Jun;38(6):1192-1194. doi: 10.1016/j.ajem.2020.02.027. Epub 2020 Feb 19.
10
Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study.严重脓毒症患者新发心房颤动的发生率、预测因素和结局：一项队列研究。
Am J Respir Crit Care Med. 2017 Jan 15;195(2):205-211. doi: 10.1164/rccm.201603-0618OC.